Two Sigma Investments, LP Cognition Therapeutics Inc Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.51 - $2.3 $27,759 - $42,283	-18,384 Reduced 39.43%	28,236 $55,000
Q4 2022 Feb 14, 2023	BUY	$1.17 - $3.51 $25,989 - $77,967	22,213 Added 91.01%	46,620 $97,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $3.6 $40,759 - $87,865	24,407 New	24,407 $46,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.45 $63,153 - $145,251	-42,102 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.41 - $6.9 $99,523 - $284,942	-41,296 Reduced 49.52%	42,102 $116,000

Q4 2021 Feb 14, 2022	BUY	$5.1 - $12.98 $425,329 - $1.08 Million	83,398 New	83,398 $527,000

9.4M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $43.4M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.